Organization
National Research Council, Ottawa
2 abstracts
Abstract
14-3-3ETA AS A NOVEL RA DRUG TARGET: ANTI-14-3-3ETA MONOCLONAL ANTIBODY DELAYS THE ONSET AND MITIGATES THE SEVERITY OF ARTHRITIS IN CIA MICE Org: National Research Council, Ottawa, Augurex Life Sciences Corp, North Vancouver, Canada, University of Alberta, Edmonton, Canada,
Abstract
14-3-3ETA BIOMARKER DYNAMICS IN CIA MARK DISEASE SEVERITY IN A NON-INTERVENTIONAL STUDY Org: National Research Council, Ottawa, U of Alberta, Edmonton, Augurex, Vancouver, Canada,